← All trials
NCT01594931
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2005
- Primary completion
- Mar 1, 2006
- Completion date
- Apr 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 477
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Medicines for Malaria VentureLead sponsor
- Bethesda Hospital, Tomohon, North Sulawasi, IndonesiaOverall official - principal investigator
- Mahidol UniversityOverall official - principal investigator
- Medical Research CouncilOverall official - principal investigator
- Medecins Sans FrontieresOverall official - principal investigator
- National Centre for Parasitology, Entomology and Malaria Control, CambodiaOverall official - principal investigator
- Shin Poong PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.